Neomycin Sulfate and Hydrocortisone Acetate Ophthalmic Ointment
» Neomycin Sulfate and Hydrocortisone Acetate Ophthalmic Ointment contains the equivalent of not less than 90.0 percent and not more than 135.0 percent of the labeled amount of neomycin, and not less than 90.0 percent and not more than 110.0 percent of the labeled amount of hydrocortisone acetate (C23H32O6).
Packaging and storage Preserve in collapsible ophthalmic ointment tubes.
A: It meets the requirements for neomycin under Thin-Layer Chromatographic Identification Test 201BNP.
B: The retention time of the major peak for hydrocortisone acetate in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay for hydrocortisone acetate.
Sterility 71 It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined.
Minimum fill 755: meets the requirements.
Water, Method I 921: not more than 1.0%, 20 mL of a mixture of toluene and methanol (7:3) being used in place of methanol in the titration vessel.
Metal particles It meets the requirements of the test for Metal Particles in Ophthalmic Ointments 751.
Assay for neomycin Proceed with Ophthalmic Ointment as directed in the Assay under Neomycin Sulfate Ointment.
Assay for hydrocortisone acetate Proceed with Ophthalmic Ointment as directed in the Assay under Hydrocortisone Acetate Lotion.
Auxiliary Information Please check for your question in the FAQs before contacting USP.Chromatographic Column
USP32NF27 Page 3053Pharmacopeial Forum: Volume No. 30(2) Page 518
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.